Carl Hittinger, Maurice Valla Speak on Pharma Exclusivity Considerations

News / March 22, 2016
Partners Carl Hittinger and Maurice Valla were speakers at the March 16, 2016, Health, Biotech & Pharma Law CLE Institute sponsored by the Association of Corporate Counsel Greater Philadelphia. Hittinger and Valla, joined by Joseph C. Wang, a R&D regulatory attorney from Bristol-Myers Squibb, spoke on “Patient-Centered Innovation: IP, Regulatory and Antitrust Considerations in Pharmaceutical Product Development.”